Skip to main content
  1. Right Decisions
  2. Borders Ref Help Toolkit (in development)
  3. Back
  4. Headache
  5. 1. National headache pathway
Important: please update your RDS app to version 4.7.3

Welcome to the March 2025 update from the RDS team

1.     RDS issues - resolutions

1.1 Stability issues - Tactuum implemented a fix on 24th March which we believe has finally addressed the stability issues experienced over recent weeks.  The issue seems to have been related to the new “Tool export” function making repeated calls for content when new toolkit nodes were opened in Umbraco. No outages have been reported since then, and no performance issues in the logs, so fingers crossed this is now resolved.

1.2 Toolkit URL redirects failing– these were restored manually for the antimicrobial calculators on the 13th March when the issue occurred, and by 15th March for the remainder. The root cause was traced to adding a new hostname for an app migrated from another health board and made live that day. This led to the content management system automatically creating internal duplicate redirects, reaching the maximum number of permitted redirects and most redirects therefore ceasing to function.

This issue should not happen again because:

  • All old apps are now fully migrated to RDS. The large number of migrations has contributed to the high number of automated redirects.
  • If there is any need to change hostnames in future, Tactuum will immediately check for duplicates.

1.3 Gentamicin calculators – Incidents have been reported incidents of people accessing the wrong gentamicin calculator for their health board.  This occurs when clinicians are searching for the gentamicin calculator via an online search engine - e.g. Google - rather than via the health board directed policy route. When accessed via an external search engine, the calculator results are not listed by health board, and the start page for the calculator does not make it clearly visible which health board calculator has been selected.

The Scottish Antimicrobial Prescribing Group has asked health boards to provide targeted communication and education to ensure that clinicians know how to access their health board antimicrobial calculators via the RDS, local Intranet or other local policy route. In terms of RDS amendments, it is not currently possible to change the internet search output, so the following changes are now in progress:

  • The health board name will now be displayed within the calculator and it will be made clear which boards are using the ‘Hartford’ (7mg/kg) higher dose calculator
  • Warning text will be added to the calculator to advise that more than one calculator is in use in NHS Scotland and that clinicians should ensure they access the correct one for their health board. A link to the Right Decision Service list of health board antimicrobial prescribing toolkits will be included with the warning text. Users can then access the correct calculator for their Board via the appropriate toolkit.

We would encourage all editors and users to use the Help and Support standard operating procedure and the Editors’ Teams channel to highlight issues, even if you think they may be temporary or already noted. This helps the RDS team to get a full picture of concerns and issues across the service.

 

2.     New RDS presentation – RDS supporting the patient journey

A new presentation illustrating how RDS supports all partners in the patient journey – multiple disciplines across secondary, primary, community and social care settings – as well as patients and carers through self-management and shared decision-making tools – is now available. You will find it in the Promotion and presentation resources for editors section of the Learning and support toolkit.

3.     User guides

A new user guide is now available in the Guidance and tips section of Resources for providers within the Learning and Support area, explaining how to embed content from Google Calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream and Jotforms into RDS pages. A webinar for editors on using this new functionality is scheduled for 1 May 3-4 pm (booking information below.)

A new checklist to support editors in making all the checks required before making a new toolkit live is now available at the foot of the “Request a new toolkit” standard operating procedure. Completing this checklist is not a mandatory part of the governance process, but we would encourage you to use it to make sure all the critical issues are covered at point of launch – including organisational tags, use of Alias URLs and editorial information.

4.Training sessions for RDS editors

Introductory webinars for RDS editors will take place on:

  • Tuesday 29th April 4-5 pm
  • Thursday 1st May 4-5 pm

Special webinar for RDS editors – 1 May 3-4 pm

This webinar will cover:

  1. a) Use of the new left hand navigation option for RDS toolkits.
  2. b) Integration into RDS pages of content from external sources, including Google Calendar, Google Maps and simple Jotforms calculators.

Running usage statistics reports using Google analytics

  • Wednesday 23rd April 2pm-3pm
  • Thursday 22nd May 2pm-3pm

To book a place on any of these webinars, please contact Olivia.graham@nhs.scot providing your name, role, organisation, title and date of the webinar you wish to attend.

5.New RDS toolkits

The following toolkits were launched during March 2025:

SIGN guideline - Prevention and remission of type 2 diabetes

Valproate – easy read version for people with learning disabilities (Scottish Government Medicines Division)

Obstetrics and gynaecology induction toolkit (NHS Lothian) – password-protected, in pilot stage.

Oral care for care home and care at home services (Public Health Scotland)

Postural care in care homes (NHS Lothian)

Quit Your Way Pregnancy Service (NHS GGC)

 

6.New RDS developments

Release of the redesign of RDS search and browse, archiving and version control functionality, and editing capability for shared content, is now provisionally scheduled for early June.

The Scottish Government Realistic Medicine Policy team is leading development of a national approach to implementation of Patient-Reported Outcome Measures (PROMs) as a key objective within the Value Based Health and Care Action Plan. The Right Decision Service has been commissioned to deliver an initial version of a platform for issuing PROMs questionnaires to patients, making the PROMs reports available from patient record systems, and providing an analytics dashboard to compare outcomes across services.  This work is now underway and we will keep you updated on progress.

The RDS team has supported Scottish Government Effective Prescribing and Therapeutics Division, in partnership with Northern Ireland and Republic of Ireland, in a successful bid for EU funding to test develop, implement and assess new integrated care pathways for polypharmacy, including pharmacogenomics. As part of this project, the RDS will be working with NHS Tayside to test extending the current polypharmacy RDS decision support in the Vision primary care electronic health record system to include pharmacogenomics decision support.

7. Implementation projects

We have just completed a series of three workshops consulting on proposed improvements to the Being a partner in my care: Realistic Medicine together app, following piloting on 10 sites in late 2024. This app has been commissioned by Scottish Government Realistic Medicine to support patients and citizens to become active partners in shared decision-making and encouraging personalised care based on outcomes that matter to the person. We are keen to gather more feedback on this app. Please forward any feedback to ann.wales3@nhs.scot

 

 

1. National headache pathway

Warning

Background

The following diagram gives an overview of the primary care pathway (through to the interface with secondary care) based on presentation at General Practice. 

National headache pathway

Most patients presenting to health services with headaches have primary headache (up to 95% presenting to primary care and over 50% presenting to A&E). The most common primary headache is migraine, making up the majority of these patients. Most patients with migraine can be adequately managed in primary care. Some patients, particularly those with more frequent headache may need input from secondary care.

The following diagram lists the important red, amber and green flags:

Most patients do not have serious secondary headache. Red flags indicate the need for urgent assessment to exclude a secondary cause. The most consistent indicators for serious secondary causes for headache are:

  1. Thunderclap (sudden onset) headache (consider SAH and its differential)
  2. New focal neurological deficit on examination (e.g. hemiparesis)
  3. Systemic features (considering GCA, infection such as meningitis or encephalitis, etc)
  4. New progressive headache in a patient over 50 (most headaches presenting in patients
    over 50 are benign, but there is an increased risk of secondary pathology with
    increasing age)

Thunderclap headache is usually occipital or global. It is defined as a severe abrupt onset headache, usually reaching its peak instantaneously, but headache can progress over up to 5 minutes. The main consideration is subarachnoid haemorrhage, but other causes include cervical artery dissection, intracranial haemorrhage, posterior circulation stroke, cerebral venous sinus thrombosis and spontaneous intracranial hypotension.

Anyone presenting with a thunderclap headache should have a same day referral (which may be through A&E), even in delayed presentations.

A new focal neurological symptom (eg seizure) or sign (eg hemiparesis) in a patient with a new progressive headache indicates the possibility of an intracranial pathology and this should prompt an urgent referral for assessment and appropriate imaging. The referring clinical should decide whether this merits attendance at A&E, a call to the appropriate specialist service or an urgent referral. Specific syndromes that may indicate the possibility of a brain tumour are listed below, but extra dural / sub dural haematomas, cerebral venous sinus thrombosis, viral encephalitis and other intracranial pathology can present similarly.


Headache suggesting the possibility of a brain tumour

  1. New headache plus sub-acute progressive focal neurology
  2. New headache plus seizures
  3. New headache with personality or cognitive change not suggestive of dementia, with no
    psychiatric history and confirmed by witness

Fever, neck stiffness and rash should raise the consideration of infection such as meningitis and constitutional symptoms and scalp tenderness should raise the consideration of Giant Cell Arteritis (GCA).

Most headache in older patients will have a benign cause (mainly migraine), but the clinician should have a lower threshold for considering a secondary cause in an older patient with a new persisting or worsening headache. Anyone over 50 with a new headache should have a CRP +/- plasma viscosity +/- ESR + FBC as per local protocol to consider GCA. Anyone where this is a serious consideration should have an urgent referral and consideration of steroids as per local protocol.

 

Features that may indicate a secondary cause but may also be seen in primary headaches:

  1. Changes in headache intensity with changes of posture (upright consider low pressure / headache when lying flat consider high pressure)
  2. Worsening/Triggering headache with Valsalva (e.g. coughing, straining)
  3. Atypical aura (duration >1 hour or including motor weakness)
  4. Progressive headache (worsening over weeks or longer)
  5. Head trauma within the last month
  6. Previous history of cancer or HIV
  7. Re-attendance to A&E or GP surgery with progressively worsening headache severity or frequency

Consider a secondary cause if any of these are present.

Orthostatic headache should have a consistent onset / worsening on assuming an upright posture and offset / significant improvement on lying flat. This should be differentiated from headache which improves on lying still, which is a feature of migraine. Early assessment and treatment of Spontaneous Intracranial Hypotension (SIH) improves outcomes and patients with orthostatic headache should be referred urgently. Further information is available in the consensus guidelines on SIH.

Headache wakening the patient, headache present on wakening which then improves after assuming an upright posture and Valsalva headache (headache triggered by coughing or other Valsalva manoeuvres) raises the possibility of raised intracranial pressure. Headache present on wakening which improves after assuming an upright posture may also be due to cervicogenic headache and obstructive sleep apnoea or other causes of nocturnal hypoventilation. Migraine starting in sleep is the commonest cause for wakening with a headache (especially if the headache is intermittent). It is also important to consider Medication Overuse Headache as
“wearing off” of the overused medication during sleep can result in wakening with a headache which then improves with taking the overused medication. These patients are likely to have migraine.

Normal imaging does not exclude raised intracranial pressure and it is important to examine the patient for papilloedema. An urgent optician assessment should be considered where the clinician is not confident undertaking ophthalmoscopy. More detail on the assessment and management of Intracranial Hypertension can be found on (insert link). Due to risk to vision, patients should be referred same day as per local protocol, usually to ophthalmology in the first instance.

A history of cancer, immunosuppression (including HIV) and recent head trauma in a patient with new progressive headache should raise the consideration of secondary brain tumour, infection or intracranial haemorrhage. These patients usually have other features in addition to headache.

Features that do not help to differentiate primary from secondary headaches are:

  1. Severity
  2. Treatment response

 

Features that are supportive of a diagnosis of primary headache:

  1. Recurrent episodic headache, particularly with features of migraine
  2. Long history of daily headache

If there are no concerning features then it is appropriate to manage these patients for migraine.

Other features that are pointers to migraine include a previous migraine history and a family history of migraine.

 

Migraine is the commonest primary headache presenting to both primary and secondary care. It is however important to consider other primary headache disorders as per the following table. 

Please note that this table may require both horizontal and vertical scrolling to view all content in the mobile app version.

Headache feature  Migraine (with or without aura)  Cluster headache  Tension-type headache 
Frequency  Majority of patients presenting to both primary and secondary care (94% of people presenting in primary care with episodic headache will have migraine)  Rare - 1 in 1,000  Very common, but not  often seen in primary or secondary care as usually mild and self-managed 
Duration of headache 

4 – 72 hours in adults 

1 – 72 hours in young people 

15 minutes to 3 hours  30 minutes – continuous 
Pain location 

Unilateral or bilateral 

(head, face or neck) 

Unilateral (around the eye, above the eye and along the side of the head/face) 

Bilateral 

(head, face or neck) 

Pain quality 

Pulsating 

(throbbing or banging in young people) 

Variable (can be sharp, boring, burning, throbbing or tightening) 

Pressing/tightening 

(non-pulsating) 

Pain intensity  Moderate or severe  Severe or very severe  Mild or moderate 
Effect of activities 

Aggravated by, or causes avoidance of, routine activities of daily living 

(e.g. prefer to stay still or go to bed) 

Restlessness or agitation  Not aggravated by routine activities of daily living 
Other symptoms 
  • Photophobia (sensitivity to light) 
  • Phonophobia (sensitivity to sound) 
  • Nausea and/or vomiting 
  • Allodynia (sensitivity to touch) 
  • Cranial autonomic symptoms 
  • Aura (lasts 5 – 60 minutes) can include: 
  • Flickering lights, spots or lines and/or partial loss of vision 
  • Sensory symptoms such as numbness and/or pins and needles 
  • Speech disturbance 

Cranial autonomic symptoms on the same side as the headache: 

  • Red and/or watery eye 
  • Nasal congestion and/or runny nose 
  • Swollen eyelid 
  • Forehead and facial sweating 
  • Constricted pupil and/or drooping eyelid 

Patients with cluster can get migrainous symptoms and aura 

None 

 

Migraine is differentiated into episodic and chronic migraine 

Patients with episodic have migraine on 14 or less days per month (high frequency episodic migraine 10-14 days per month). 

Patients with chronic migraine have 15 or more days of headache per month 8 of which should meet criteria for migraine. Chronic migraine therefore usually presents with a mixture of milder background headache and migraine. 

 

  • Patients with migraines often underplay their symptoms 
  • Recurrent ‘sinus headache’ and/or dizziness is usually migraine 
  • In patients with chronic migraine, there is usually background headache with superimposed migraine days 
  • In patients taking acute treatment on >10 days/month, consider medication overuse headache 
  • Most patients waking with headache have migraine or medication overuse headache (withdrawal of overused analgesia overnight) 
  • Menstrual headache is almost always migraine and migraine usually improves in pregnancy 
  • Most patients with migraine are sensitive to head movement during a migraine so bending, coughing or sneezing during a migraine may make headache worse (motion sensitivity) 
  • Most patients with migraine don't have aura  
  • 40% of migraine is bilateral 

 

Migraine is the most likely diagnosis for a patient attending primary care with headache. Many of these patients will be successfully managed in primary care. If there is a clear diagnosis of migraine we recommend acute +/- preventative treatment (as detailed in the acute and preventative treatment sections).  

Where preventative treatment is not successful after a trial of three preventative medications at an adequate dose and for an adequate length of time, consider referral to relevant secondary care services as per local arrangements.

If there is diagnostic uncertainty or concern about a secondary cause, consider open access CT as an alternative to secondary care referral. 

 

Patients should be directed to the resources available on NHS Inform to for lifestyle advice. Where consultation time allows the following key points should be made in relation to lifestyle. 

  1. Regular sleep pattern. 
  2. Regular eating pattern / don’t skip meals (more frequent small meals may help). 
  3. Regular fluid intake but limit alcohol, and limit caffeine from tea, coffee and some soft drinks. 
  4. Regular physical activity/exercise 
  5. Regular breaks from computers/phone screens  
  6. Relaxation activities such as mindfulness, yoga or meditation 

Manage potential triggers as needed; e.g. avoid perfumes, certain food triggers if applicable, bright, flashing or flickering lights (consider wearing sunglasses when outside or in bright, flashing or flickering light) 

Further advice is available from the Migraine Trust on 0808 802 0066 or https://migrainetrust.org/what-we-do/our-information-and-support-service/ 

 

  1. SIGN 155 Clinician Guidance SIGN 155 Pharmacological management of migraine 2023 update 
  2. SIGN 155 patient guidance SIGN Migraine patient booklet PAT155 (revised 2022) 
  3. Heads up podcasts from the National Migraine Centre Heads Up podcast - National Migraine Centre 
  4. British Association for the Study of Headache - Headache management system 
  5. Headache UK Optimal clinical pathway for adults with headache and facial pain. NNAG (National Neurosciences Advisory Group). 2023.
  6. Optimal clinical pathway for adults with headache and facial pain — National Neurosciences Advisory Group (nnag.org.uk) 
  7. Mollan S. et al. Evaluation and Management of adult idiopathic intracranial hypertension. Practical Neurology. 2018. Evaluation and management of adult idiopathic intracranial hypertension (bmj.com) 
  8. Cheema S. et al. Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension. JNNP. 2023. https://jnnp.bmj.com/content/early/2023/05/04/jnnp-2023-331166 

 

   gjnh.cfsdpmo@gjnh.scot.nhs.uk

  www.nhscfsd.co.uk

@NHSScotCfSD

Centre for Sustainable Delivery

  Scan the code to visit our website

Editorial Information

Last reviewed: 11/10/2023

Next review date: 01/04/2025

Author(s): Centre for Sustainable Delivery.